Experts urge FDA on diabetes medication

Thu, 03 Jul 2008
Further diabetes reports indicate that the expert panel being consulted by the Food and Drug Administration in America is calling for potential diabetes drugs to be reviewed in terms of their heart risks before approval.

The advisory panel helping the FDA could cause a major change in legislation. The change could require drug manufacturers to change their diabetes trials, and potentially delay new drugs entering the market.

The concerns and change was prompted by major public outcry against diabetes drug Avandia, which reportedly increases risk of heart disease and death. The experts advising the FDA voted overwhelmingly for companies to do long-term cardiovascular studies.
Leave a Comment
Login via Facebook, Yahoo! and Hotmail
or
Have your full say in the Diabetes Forum
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.